Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0000950170-25-032747 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-03-04 | 2025-03-04 | CORT | Guyer William | Chief Development Off | S - Sale+OE | $59.07 | -20.0K | 5,487 | -78% | -$1.18M |
| DT | 2025-03-04 | 2025-03-04 | CORT | Guyer William | Chief Development Off | M - OptEx | $19.26 | +20.0K | 25.5K | +364% | +$385.2K |
| DT | 2025-03-04 | 2025-03-04 | CORT | Guyer William | Chief Development Off | M - OptEx | $0.00 | -20.0K | 30.0K | -40% | $0 |
| DT | 2025-03-04 | 2025-02-28 | CORT | Guyer William | Chief Development Off | A - Grant | $0.00 | +140.0K | 140.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-04 | S | D | 20,000 | $59.07 | 5,487 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-04 | M | A | 20,000 | $19.26 | 25,487 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2025-03-04 | M | D | 20,000 | $0.00 | 30,000 | D | $19.26 · — to 2032-02-02 | 20,000 Common Stock | (F3) Fully exercisable. |
| 4 | Derivative | Stock option (right to buy) | 2025-02-28 | A | A | 140,000 | $0.00 | 140,000 | D | $60.58 · — to 2035-02-28 | 140,000 Common Stock | (F2) Exercise ratably in equal installments on each monthly anniversary of February 28, 2025 over a four-year period subject to the Reporting Person's continued service through each vesting date. |